{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Disorders", "query": { "condition": "Eye Disorders" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 5610, "total_pages": 561, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Disorders&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T11:25:14.581Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01492400", "title": "Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Macular Edema" ], "interventions": [ { "name": "dexamethasone Intravitreal Implant", "type": "DRUG" }, { "name": "ranibizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 363, "start_date": "2012-03-09", "completion_date": "2014-02-13", "has_results": true, "last_update_posted_date": "2019-04-17", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01492400" }, { "nct_id": "NCT01527500", "title": "Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Geographic Atrophy", "Age-related Macular Degeneration" ], "interventions": [ { "name": "LFG316", "type": "DRUG" }, { "name": "Sham", "type": "DRUG" }, { "name": "LFG316 Lower dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 158, "start_date": "2012-01-25", "completion_date": "2015-06-24", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Beverly Hills, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01527500" }, { "nct_id": "NCT04139798", "title": "Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye Disease (DED)" ], "interventions": [ { "name": "NOV03", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 599, "start_date": "2020-07-20", "completion_date": "2021-03-12", "has_results": true, "last_update_posted_date": "2024-10-23", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Glendale, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04139798" }, { "nct_id": "NCT00447187", "title": "Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Corneal Diseases", "Cornea Transplant" ], "interventions": [ { "name": "LX201", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Lux Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 368, "start_date": "2007-04", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2012-10-11", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Loma Linda, California • Los Angeles, California + 19 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00447187" }, { "nct_id": "NCT00332293", "title": "AL-15469A for the Treatment of Bacterial Conjunctivitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Conjunctivitis" ], "interventions": [ { "name": "Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%", "type": "DRUG" }, { "name": "Moxifloxacin hydrochloride ophthalmic solution 0.5% as base", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": null, "sex": "ALL", "summary": "1 Month and older" }, "enrollment_count": 695, "start_date": "2006-05", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2016-11-18", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00332293" }, { "nct_id": "NCT05945784", "title": "Exploring Accessible Beauty for Individuals With Upper Extremity Deficits", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke, Ischemic", "Stroke Hemorrhagic", "Stroke (CVA) or TIA", "Stroke, Acute", "Traumatic Brain Injury", "SCI - Spinal Cord Injury", "Ehlers-Danlos Syndromes (EDS)", "Lupus Erythematosus", "Guillain-Barre Syndrome", "Multiple Sclerosis", "Myasthenia Gravis", "Amyotrophic Lateral Sclerosis", "Graves Disease", "Muscular Dystrophies" ], "interventions": [ { "name": "Use of Rare Beauty makeup products", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Casa Colina Hospital and Centers for Healthcare", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 57, "start_date": "2023-07-21", "completion_date": "2023-09-29", "has_results": false, "last_update_posted_date": "2023-12-06", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 1, "location_summary": "Pomona, California", "locations": [ { "city": "Pomona", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05945784" }, { "nct_id": "NCT03318549", "title": "BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Glaucoma", "Macular Degeneration", "Glaucoma Suspect", "Optic Neuropathy", "Retinal Degeneration", "Visual Pathway Disorder" ], "interventions": [ { "name": "Visual Performance tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Brain-computer interface", "type": "DEVICE" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DEVICE" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 115, "start_date": "2018-10-29", "completion_date": "2023-05-31", "has_results": true, "last_update_posted_date": "2024-11-26", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03318549" }, { "nct_id": "NCT05012358", "title": "Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mitochondrial Myopathies", "Mitochondrial DNA Mutation", "Mitochondrial Diseases", "Chronic Progressive External Ophthalmoplegia With Myopathy", "Kearns-Sayre Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "15 Years to 80 Years" }, "enrollment_count": 9, "start_date": "2022-05-01", "completion_date": "2024-01-22", "has_results": false, "last_update_posted_date": "2024-06-12", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05012358" }, { "nct_id": "NCT00399230", "title": "A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "Optive", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-08-21", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 1, "location_summary": "McLean, Virginia", "locations": [ { "city": "McLean", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00399230" }, { "nct_id": "NCT01748292", "title": "Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Degeneration" ], "interventions": [ { "name": "0.5 mg ranibizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Charles C Wykoff, PhD, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 60, "start_date": "2012-12", "completion_date": "2017-02", "has_results": true, "last_update_posted_date": "2019-06-04", "last_synced_at": "2026-06-10T11:25:14.581Z", "location_count": 4, "location_summary": "West Columbia, South Carolina • Houston, Texas • Katy, Texas + 1 more", "locations": [ { "city": "West Columbia", "state": "South Carolina" }, { "city": "Houston", "state": "Texas" }, { "city": "Katy", "state": "Texas" }, { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01748292" } ] }